2024-12-27 02:15:55
Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates
Corporate/ 2023-07-24
Novavax Announces Initiation of Phase 2 ...

GAITHERSBURG,Md.,Dec. 31,2022--Novavax,Inc. (Nasdaq: NVAX),a biotechnology company dedicated to developing and commercializing next-generati...

Ascletis Believes that the Complaints Made by Viking Therapeutics Have No Merit and will Vigorously Defend Against such Complaints
Corporate/ 2023-07-24
Ascletis Believes that the Complaints Ma...

HANGZHOU and SHAOXING,China,Jan. 2,2023--Ascletis Pharma Inc. (HKEX: 1672,"Ascletis") was recently informed that on December 29,20...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release